Measuring Adherence to Medication for Depression and Attention-deficit Hyperactivity Disorder
|ClinicalTrials.gov Identifier: NCT01430767|
Recruitment Status : Completed
First Posted : September 8, 2011
Last Update Posted : April 20, 2017
|Condition or disease|
|Major Depressive Disorder Attention-deficit Hyperactivity Disorder (ADHD)|
|Study Type :||Observational|
|Actual Enrollment :||33 participants|
|Official Title:||Measuring Adherence to Standard-of-Care Medication for Depression and ADHD in a College Student Population|
|Study Start Date :||September 2011|
|Primary Completion Date :||December 2014|
|Study Completion Date :||December 2014|
Ten subjects with diagnosis of major depressive disorder from the Wake Forest University Student Health Clinic, being treated with FDA-approved standard-of-care medication for depression.
Ten subjects with a diagnosis of attention-deficit hyperactivity disorder (ADHD) from the Wake Forest University Student Health Clinic, being treated with FDA-approved standard-of-care medication for their ADHD.
- Adherence to Standard-of-Care Medication for Depression or ADHD [ Time Frame: 4 weeks ]Adherence to standard-of-care medication for depression or ADHD will be objectively measured using a bottle fitted with a Medication Event Monitoring System (MEMS®) cap and the percentage of prescribed doses taken will be reported as the outcome.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01430767
|United States, North Carolina|
|Wake Forest University Health Sciences|
|Winston-Salem, North Carolina, United States, 27157|
|Principal Investigator:||Guy K Palmes, MD||Wake Forest University Health Sciences|